C57BL/6JCya-Plod1em1flox/Cya
Common Name:
Plod1-flox
Product ID:
S-CKO-17845
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Plod1-flox
Strain ID
CKOCMP-18822-Plod1-B6J-VB
Gene Name
Product ID
S-CKO-17845
Gene Alias
2410042F05Rik; Lh1; Plod
Background
C57BL/6JCya
NCBI ID
Modification
Conditional knockout
Chromosome
4
Phenotype
Document
Application
--
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Plod1em1flox/Cya mice (Catalog S-CKO-17845) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000019199
NCBI RefSeq
NM_011122
Target Region
Exon 2~5
Size of Effective Region
~3.8 kb
Detailed Document
Overview of Gene Research
Plod1, also known as procollagen-lysine, 2-oxoglutarate 5-dioxygenase 1, is a collagen-related lysyl hydroxylase. It is involved in important biological processes, and its associated pathways include Wnt/β-catenin, HSF1, Hippo-YAP, SOX9/PI3K/Akt/mTOR, and NF-κB signaling pathways. It plays a role in various physiological and pathological conditions, especially in cancer development and vascular diseases [1-9].
In multiple cancer types, loss-of-function experiments have provided insights into Plod1's role. In thyroid carcinoma (THCA), si-Plod1 inhibited cell proliferation, migration, and glycolysis, reversing the effects induced by the transcription factor MAZ on cell activities through the Wnt/β-catenin pathway [1]. In glioma, targeted depletion of Plod1 suppressed U87 cell proliferation and colony formation by inactivating the HSF1 signaling pathway [3]. In osteosarcoma, down-regulation of Plod1 inhibited cell proliferation, migration, and invasion, and it was found to inactivate the Hippo-YAP pathway by repressing LATS1 phosphorylation [4,6]. In gastric cancer, knockdown of Plod1 decreased cell viability and aerobic glycolysis by regulating the SOX9/PI3K/Akt/mTOR signaling pathway [5]. In glioblastoma, over-expression of Plod1 promoted the malignant phenotype, and its depletion could potentially reverse these effects via the NF-κB signaling pathway [7]. In a family with familial thoracic aortic aneurysm/dissection, a missense variant in Plod1 was identified, and in vitro studies using human aortic vascular smooth muscle cells with si-Plod1 showed hypercontractility and up-regulation of contractile markers, suggesting a role in vascular disease [2].
In conclusion, Plod1 is crucial in multiple biological processes, especially in cancer and vascular diseases. Model-based research, particularly loss-of-function experiments, has revealed its role in promoting cell proliferation, migration, invasion, and glycolysis in cancer, as well as its potential involvement in vascular smooth muscle cell phenotypic switching in vascular disease. Understanding Plod1's function provides potential therapeutic targets for these diseases.
References:
1. Cong, Wei, Sun, Jingfu, Hao, Zhanyu, Gong, Maosong, Liu, Jianing. 2024. PLOD1 promote proliferation and migration with glycolysis via the Wnt/β-catenin pathway in THCA. In Genomics, 116, 110943. doi:10.1016/j.ygeno.2024.110943. https://pubmed.ncbi.nlm.nih.gov/39424162/
2. Koenig, Sara N, Cavus, Omer, Williams, Jordan, Mohler, Peter J, Bradley, Elisa A. 2021. New mechanistic insights to PLOD1-mediated human vascular disease. In Translational research : the journal of laboratory and clinical medicine, 239, 1-17. doi:10.1016/j.trsl.2021.08.002. https://pubmed.ncbi.nlm.nih.gov/34400365/
3. Yuan, Bo, Xu, Yimin, Zheng, Shaoqin. 2021. PLOD1 acts as a tumor promoter in glioma via activation of the HSF1 signaling pathway. In Molecular and cellular biochemistry, 477, 549-557. doi:10.1007/s11010-021-04289-w. https://pubmed.ncbi.nlm.nih.gov/34845571/
4. Wu, Xiaolin, Xiang, Hongfei, Cong, Wenbin, Shen, Yanqing, Chen, Bohua. 2020. PLOD1, a target of miR-34c, contributes to cell growth and metastasis via repressing LATS1 phosphorylation and inactivating Hippo pathway in osteosarcoma. In Biochemical and biophysical research communications, 527, 29-36. doi:10.1016/j.bbrc.2020.04.052. https://pubmed.ncbi.nlm.nih.gov/32446383/
5. Zhang, Yixin, Wu, Yingjie, Su, Xiaobao. . PLOD1 promotes cell growth and aerobic glycolysis by regulating the SOX9/PI3K/Akt/mTOR signaling pathway in gastric cancer. In Frontiers in bioscience (Landmark edition), 26, 322-334. doi:10.52586/4946. https://pubmed.ncbi.nlm.nih.gov/34455762/
6. Jiang, Haoli, Guo, Wei, Yuan, Shanyou, Song, Lixia. 2020. PLOD1 Is a Prognostic Biomarker and Mediator of Proliferation and Invasion in Osteosarcoma. In BioMed research international, 2020, 3418398. doi:10.1155/2020/3418398. https://pubmed.ncbi.nlm.nih.gov/33134376/
7. Wang, Zhenlin, Shi, Yuping, Ying, Chenting, Jiang, Yang, Hu, Jiangfeng. 2021. Hypoxia-induced PLOD1 overexpression contributes to the malignant phenotype of glioblastoma via NF-κB signaling. In Oncogene, 40, 1458-1475. doi:10.1038/s41388-020-01635-y. https://pubmed.ncbi.nlm.nih.gov/33420370/
Quality Control Standard
Sperm Test
Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.
Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.
Environmental Standards:SPF
Available Region:Global
Source:Cyagen